ML-109 is primarily used in research settings as a potent and selective inhibitor of the NLRP3 inflammasome. This makes it a valuable tool for studying inflammatory pathways and related diseases. By inhibiting NLRP3, ML-109 helps researchers investigate the role of this inflammasome in conditions such as autoimmune disorders, neurodegenerative diseases, and metabolic syndromes. Its application extends to preclinical studies aimed at understanding the mechanisms of inflammation and evaluating potential therapeutic strategies for inflammatory and immune-mediated diseases. ML-109 is also utilized in the development of novel anti-inflammatory drugs, providing insights into targeting NLRP3 for therapeutic benefits.